Eric Lalanne
Direttore/Membro del Consiglio presso Oryzon Genomics Diagnóstico SL
Profilo
Eric Lalanne is currently a Director at Oryzon Genomics Diagnóstico SL.
He previously worked as a Director-In Vitro Diagnostics at Oryzon Genomics SA. Lalanne holds a doctorate degree from Université Paris 1 Panthéon-Sorbonne and undergraduate and graduate degrees from Université Toulouse III - Paul Sabatier.
Posizioni attive di Eric Lalanne
| Società | Posizione | Inizio |
|---|---|---|
Oryzon Genomics Diagnóstico SL
 Oryzon Genomics Diagnóstico SL Medical SpecialtiesHealth Technology Oryzon Genomics Diagnóstico SL develops oncology diagnostic solutions. It operates as a IVD company that engages in developing and commercializing molecular diagnostics for oncology. The firm's product GynEC-DX, a molecular test for endometrial cancer detection. The company was founded in 2013 and is headquartered in Barcelona, Spain. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Eric Lalanne
| Società | Posizione | Fine |
|---|---|---|
| ORYZON GENOMICS S.A. | Corporate Officer/Principal | - |
Formazione di Eric Lalanne
| Université Toulouse III - Paul Sabatier | Graduate Degree |
| Université Paris 1 Panthéon-Sorbonne | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ORYZON GENOMICS S.A. | Health Technology |
| Aziende private | 1 |
|---|---|
Oryzon Genomics Diagnóstico SL
Oryzon Genomics Diagnóstico SL Medical SpecialtiesHealth Technology Oryzon Genomics Diagnóstico SL develops oncology diagnostic solutions. It operates as a IVD company that engages in developing and commercializing molecular diagnostics for oncology. The firm's product GynEC-DX, a molecular test for endometrial cancer detection. The company was founded in 2013 and is headquartered in Barcelona, Spain. | Health Technology |
- Borsa valori
- Insiders
- Eric Lalanne
